https://orcid.org/0000-0003-1400-4427
Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Sara Salatin, Mina Tarzamani, Afsaneh Farjami & Mitra Jelvehgari. (2022) Development and Characterization of a Novel Mucoadhesive sol-gel Suppository of Sumatriptan: design, optimization, In Vitro and Ex Vivo Evaluation for Rectal Drug Delivery. Therapeutic Delivery 13:2, pages 95-108.
Read now
Read now
Articles from other publishers (14)
Shengyuan Yu, Aihong Guo, Zhen Wang, Jianguang Liu, Ge Tan, Qian Yang, Mingjie Zhang, Hasiyeti Yibulaiyin, Huisheng Chen, Yongbo Zhang, Robert Croop, Yanhui Sun, Yu Liu, Qian Zhao & Zhihong Lu. (2024) Rimegepant orally disintegrating tablet 75 mg for acute treatment of migraine in adults from China: a subgroup analysis of a double-blind, randomized, placebo-controlled, phase 3 clinical trial. The Journal of Headache and Pain 25:1.
Crossref
Crossref
Dimos D. Mitsikostas & Thomas N. Ward. 2024. Migraine Management. Migraine Management
203
218
.
G. R. Tabeeva & O. V. Kosivtsova. (2023) Modern strategies for the treatment of migraine attacks and the possibility of a differentiated approach. Meditsinskiy sovet = Medical Council:21, pages 54-62.
Crossref
Crossref
Sara Hisham, Ayat Manzour, Mohammed M. Fouad, Randa M. Amin, Hisham A. Hatata & Diaa Marzouk. (2023) Effectiveness of integrated education and relaxation program on migraine-related disability: a randomized controlled trial. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 59:1.
Crossref
Crossref
Muhammad Waqas, Faizan Ur Rehman Ansari, Anam Nazir, Khadija Saleem Raza Hussain, Zouina Sarfraz, Azza Sarfraz, Muzna Sarfraz & Manish KC. (2023) Zavegepant nasal spray for the acute treatment of migraine: A meta analysis. Medicine 102:43, pages e35632.
Crossref
Crossref
Elisabeth Callen, Tarin Clay, Jillian Alai, Paul Crawford, Adam Visconti, Andrea Nederveld, Inez Cruz, Bailey Perez, Karen L Roper, Tamara K Oser, May-Lorie Saint Laurent & Yalda Jabbarpour. (2023) Migraine care practices in primary care: results from a national US survey. Family Practice.
Crossref
Crossref
Dai-gang Yang, Yong-yao Gao, Ze-qun Yin, Xue-rui Wang, Xian-she Meng, Ting-feng Zou, Ya-jun Duan, Yuan-li Chen, Chen-zhong Liao, Zhou-ling Xie, Xiao-dong Fan, Lu Sun, Ji-hong Han & Xiao-xiao Yang. (2022) Roxadustat alleviates nitroglycerin-induced migraine in mice by regulating HIF-1α/NF-κB/inflammation pathway. Acta Pharmacologica Sinica 44:2, pages 308-320.
Crossref
Crossref
Andrés Felipe Morcillo Muñoz, Daniel S. Marín-Medina, Juan Camilo Castro-Rubio & Pablo Lorenzana Pombo. (2023) Migraña y ritmo delta intermitente de máximo anterior (FIRDA): un reporte de caso y revisión de tema. Neurología Argentina 15:1, pages 47-51.
Crossref
Crossref
Yasuhiko Matsumori, Mika Komori, Yuka Tanji, Akichika Ozeki & Fumihiko Sakai. (2022) Rapid Onset and Sustained Efficacy of Lasmiditan Among Japanese Patients with Migraine: Prespecified Analyses of a Randomized Controlled Trial. Neurology and Therapy 11:4, pages 1721-1734.
Crossref
Crossref
Pierangelo Geppetti, Francesco De Cesaris, Silvia Benemei, Pietro Cortelli, Sabina Cevoli, Giulia Pierangeli, Valentina Favoni, Carlo Lisotto, Susanna Usai, Fabio Frediani, Paola Di Fiore, Giacomo D'Arrigo, Cristina Tassorelli, Grazia Sances, Maria Michela Cainazzo, Carlo Baraldi, Paola Sarchielli, Ilenia Corbelli, Gioacchino De Vanna, Gioacchino Tedeschi & Antonio Russo. (2022) Self-administered subcutaneous diclofenac sodium in acute migraine attack: A randomized, double-blind, placebo-controlled dose-finding pilot study. Cephalalgia 42:10, pages 1058-1070.
Crossref
Crossref
Peter McAllister, David Kudrow, Roger Cady, Joe Hirman & Anders Ettrup. (2022) Reduction in migraine-associated burden after eptinezumab treatment in patients with chronic migraine. Cephalalgia 42:10, pages 1005-1012.
Crossref
Crossref
Cory Wilbanks. (2022) Migraine in Adult Primary Care. The Journal for Nurse Practitioners 18:4, pages 366-369.
Crossref
Crossref
Lucia Sette, Valeria Caponnetto, Raffaele Ornello, Tomáš Nežádal, Dana Čtrnáctá, Jitka Šípková, Zuzana Matoušová & Simona Sacco. (2022) Acute Medication Use in Patients With Migraine Treated With Monoclonal Antibodies Acting on the CGRP Pathway: Results From a Multicenter Study and Proposal of a New Index. Frontiers in Neurology 13.
Crossref
Crossref
Michael J. Marmura, Hans‐Christoph Diener, Robert P. Cowan, Stewart J. Tepper, Merle L. Diamond, Amaal J. Starling, Joe Hirman, Lahar Mehta, Thomas Brevig & Roger Cady. (2021) Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication‐overuse headache. Headache: The Journal of Head and Face Pain 61:9, pages 1421-1431.
Crossref
Crossref